Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions.
Leptin receptor dysfunction results in overeating and obesity. Leptin regulates hypothalamic signaling that underlies the motivation to hyperphagia, but the interaction between leptin and cannabinoid signaling is poorly understood. We evaluated the role of cannabinoid 1 receptors (CB(1)R) in overeating and the effects of food deprivation on CB(1)R in the brain. One-month-old Zucker rats were divided into unrestricted and restricted (fed 70% of unrestricted rats) diet groups and maintained until adulthood (4 months). Levels of relative binding sites of CB(1)R (CB(1)R binding levels) were assessed using [(3)H] SR141716A in vitro autoradiography. These levels were higher (except cerebellum and hypothalamus) at 4 months than at 1 month of age. One month CB(1)R binding levels for most brain regions did not differ between Ob and Lean (Le) rats (except in frontal and cingulate cortices in Le and in the hypothalamus in Ob). Four month Ob rats had higher CB(1)R binding levels than Le in most brain regions and food restriction was associated with higher CB(1)R levels in all brain regions in Ob, but not in Le rats. CB(1)R binding levels increased between adolescence and young adulthood which we believe was influenced by leptin and food availability. The high levels of CB(1)R in Ob rats suggest that leptin's inhibition of food-intake is in part mediated by downregulation of CB(1)R and that leptin interferes with CB(1)R upregulation under food-deprivation conditions. These results are consistent with prior findings showing increased levels of endogenous cannabinoids in the Ob rats corroborating the regulation of cannabinoid signaling by leptin.
Behavioral Neuropharmacology and Neuroimaging Lab, Department of Medicine, Brookhaven National Lab, Upton, NY 11973, USA. thanos@bnl.gov
Panayotis K
PK
Thanos
Roberto C
RC
Ramalhete
Michael
M
Michaelides
Yianni K
YK
Piyis
Gene-Jack
GJ
Wang
Nora D
ND
Volkow
D000367:Age Factors; D000818:Animals; D001345:Autoradiography; D001835:Body Weight / Q000502:physiology; D063385:Cannabinoid Receptor Modulators / Q000378:metabolism; D004435:Eating / Q000502:physiology; D005508:Food Deprivation / Q000502:physiology; D006963:Hyperphagia / Q000378:metabolism*; D020738:Leptin / Q000378:metabolism; D008032:Limbic System / Q000378:metabolism*; D008297:Male; D009765:Obesity / Q000378:metabolism*; D010880:Piperidines / Q000378:metabolism / Q000494:pharmacology; D011720:Pyrazoles / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D011924:Rats, Zucker; D043884:Receptor, Cannabinoid, CB1 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D054411:Receptors, Leptin / Q000172:deficiency* / Q000378:metabolism; D000077285:Rimonabant; D014316:Tritium; D015854:Up-Regulation / Q000502:physiology
D063385:Cannabinoid Receptor Modulators; D020738:Leptin; D010880:Piperidines; D011720:Pyrazoles; D043884:Receptor, Cannabinoid, CB1; D054411:Receptors, Leptin; D014316:Tritium; D000077285:Rimonabant